Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports
Mahase, Elisabeth
BMJ (Online), 2021-11, Vol.375, p.n2713-n2713
[Periódico revisado por pares]
London: British Medical Journal Publishing Group
Texto completo disponível